Thanks To Upcoming Catalysts, These Biotech Stocks Could Go From First-Half Losers To Second-Half Winners

The five biotech stocks discussed in today’s article were among the worst performers in the first half of 2021 – but thanks to upcoming catalysts, each has the potential to stage a major rebound in the second half of the year. For these five biotech stocks and their respective catalysts, CLICK HERE.